A detailed history of Versor Investments LP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Versor Investments LP holds 40,200 shares of AMRX stock, worth $320,394. This represents 0.05% of its overall portfolio holdings.

Number of Shares
40,200
Previous 13,800 191.3%
Holding current value
$320,394
Previous $87,000 283.91%
% of portfolio
0.05%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$6.42 - $8.83 $169,488 - $233,112
26,400 Added 191.3%
40,200 $334,000
Q2 2024

Aug 01, 2024

SELL
$5.36 - $7.11 $307,664 - $408,114
-57,400 Reduced 80.62%
13,800 $87,000
Q1 2024

May 13, 2024

BUY
$5.24 - $6.34 $373,088 - $451,408
71,200 New
71,200 $431,000
Q2 2022

Jul 27, 2022

BUY
$3.01 - $4.46 $402,136 - $595,856
133,600 New
133,600 $425,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.21B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.